Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer

How to develop novel treatments for EGFR-mutant lung cancer

(2015) Giuseppe Luigi Banna et al.   Future Oncology

Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2′-deoxy-2′-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC)

(2015) Joan Fledelius et al.   Journal of Medical Imaging and Radiation Oncology

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

(2014) B. Besse et al.   ANNALS OF ONCOLOGY

Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors

(2014) Lorenza Landi et al.   Clinical Lung Cancer

Early Pharmacodynamic Assessment Using 18F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction

(2014) Masaki Kanazu et al.   Clinical Lung Cancer

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

SnapShot: Cancer Metabolism Pathways

(2013) Lydia W.S. Finley et al.   Cell Metabolism

Management of non-small-cell lung cancer: recent developments

(2013) Martin Reck et al.   LANCET

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) S. Peters et al.   ANNALS OF ONCOLOGY

Early Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography

(2012) Silvia Novello et al.   Clinical Lung Cancer

Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer

(2011) Evangelia Skoura et al.   Clinical Lung Cancer

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

(2011) Christopher G. Azzoli et al.   JOURNAL OF CLINICAL ONCOLOGY

Maintenance therapy in NSCLC: why? To whom? Which agent?

(2011) Silvia Novello et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer

(2010) Dae Ho Lee et al.   Journal of Thoracic Oncology

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey

(2010) Daniel Morgensztern et al.   Journal of Thoracic Oncology

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

(2010) Federico Cappuzzo et al.   LANCET ONCOLOGY

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

(2009) Ronald Boellaard et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy

(2009) Hua-qi Zhang et al.   EUROPEAN JOURNAL OF RADIOLOGY

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials

(2008)   JOURNAL OF CLINICAL ONCOLOGY